{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:14:11Z","timestamp":1785798851636,"version":"3.56.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1245\/s10434-020-08225-y","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T18:02:53Z","timestamp":1580839373000},"page":"2664-2676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review"],"prefix":"10.1245","volume":"27","author":[{"given":"Matthew","family":"Castelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Dossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Acuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adena S.","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"issue":"9","key":"8225_CR1","first-page":"1731","volume":"71","author":"S Klein","year":"2005","unstructured":"Klein S. Evaluation of palpable breast masses. Am Fam Physician. 2005;71(9):1731\u20131738.","journal-title":"Am Fam Physician"},{"key":"8225_CR2","first-page":"9","volume":"215","author":"WJ Gradishar","year":"2019","unstructured":"Gradishar WJ, Anderson BO, Abraham J. NCCN Guidelines. Breast Cancer. 2019:215:9\u201311.","journal-title":"NCCN Guidelines. Breast Cancer."},{"issue":"5","key":"8225_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","volume":"35","author":"GH Lyman","year":"2017","unstructured":"Lyman GH, Somerfield MR, Bosserman LD, Perkins CL, Weaver DL, Giuliano AE. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35(5):561\u2013564. https:\/\/doi.org\/10.1200\/jco.2016.71.0947","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"key":"8225_CR4","doi-asserted-by":"crossref","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391\u2013398; (discussion 398\u2013401).","DOI":"10.1097\/00000658-199409000-00015"},{"issue":"30","key":"8225_CR5","doi-asserted-by":"publisher","first-page":"7703","DOI":"10.1200\/JCO.2005.08.001","volume":"23","author":"GH Lyman","year":"2005","unstructured":"Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(30):7703\u20137720. https:\/\/doi.org\/10.1200\/jco.2005.08.001","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"9","key":"8225_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599\u2013609. https:\/\/doi.org\/10.1093\/jnci\/djj158","journal-title":"J Natl Cancer Inst."},{"issue":"10","key":"8225_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u2013933. https:\/\/doi.org\/10.1016\/s1470-2045(10)70207-2","journal-title":"Lancet Oncol."},{"issue":"6","key":"8225_CR8","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/1097-0142(197712)40:6<3160::AID-CNCR2820400661>3.0.CO;2-P","volume":"40","author":"ER Fisher","year":"1977","unstructured":"Fisher ER, Redmond C, Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer. 1977;40(6):3160\u20133167.","journal-title":"Cancer."},{"issue":"8","key":"8225_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa020128","volume":"347","author":"B Fisher","year":"2002","unstructured":"Fisher B, Jeong J-H, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347(8):567\u2013575.","journal-title":"N Engl J Med."},{"issue":"2","key":"8225_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.suc.2012.12.007","volume":"93","author":"DM Black","year":"2013","unstructured":"Black DM, Mittendorf EA. Landmark trials affecting the surgical management of invasive breast cancer. Surg Clin North Am. 2013;93(2):501\u2013518. https:\/\/doi.org\/10.1016\/j.suc.2012.12.007","journal-title":"Surg Clin North Am."},{"issue":"6","key":"8225_CR11","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305(6):569\u2013575. https:\/\/doi.org\/10.1001\/jama.2011.90","journal-title":"JAMA."},{"issue":"12","key":"8225_CR12","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u20131310. https:\/\/doi.org\/10.1016\/s1470-2045(14)70460-7","journal-title":"Lancet Oncol."},{"issue":"4","key":"8225_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"\u00c1 S\u00e1volt","year":"2017","unstructured":"S\u00e1volt \u00c1, P\u00e9ley G, Polg\u00e1r C, et al. Eight-year follow up result of the OTOASOR trial: The optimal treatment of the axilla\u2014surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2017;43(4):672\u2013679. https:\/\/doi.org\/10.1016\/j.ejso.2016.12.011","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol."},{"issue":"10","key":"8225_CR14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1\u201334. https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006","journal-title":"J Clin Epidemiol."},{"issue":"9","key":"8225_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jclinepi.2008.10.012","volume":"62","author":"M Sampson","year":"2009","unstructured":"Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009;62(9):944\u2013952. https:\/\/doi.org\/10.1016\/j.jclinepi.2008.10.012","journal-title":"J Clin Epidemiol."},{"key":"8225_CR16","unstructured":"Covidence\u2014Better systematic review management. https:\/\/www.covidence.org\/home. Accessed 14 March 2019."},{"key":"8225_CR17","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, et al. The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ."},{"key":"8225_CR18","unstructured":"Treadwell J, Uhl S, Tipton K, et al. Assessing Equivalence and Noninferiority. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK98979\/. Accessed 30 July 2019."},{"issue":"24","key":"8225_CR19","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815\u20132834.","journal-title":"Stat Med."},{"key":"8225_CR20","unstructured":"7.7.7.2 Standard errors from confidence intervals and P values: difference measures. https:\/\/handbook-5-1.cochrane.org\/chapter_7\/7_7_7_2_obtaining_standard_errors_from_confidence_intervals_and.htm. Accessed 28 June 2019."},{"key":"8225_CR21","doi-asserted-by":"publisher","unstructured":"Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252(3):426\u2013432 https:\/\/doi.org\/10.1097\/sla.0b013e3181f08f32. (discussion 432\u2013433)","DOI":"10.1097\/sla.0b013e3181f08f32"},{"issue":"3","key":"8225_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264(3):413\u2013420. https:\/\/doi.org\/10.1097\/sla.0000000000001863","journal-title":"Ann Surg."},{"issue":"10","key":"8225_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u2013926. https:\/\/doi.org\/10.1001\/jama.2017.11470","journal-title":"JAMA."},{"issue":"4","key":"8225_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","volume":"14","author":"V Galimberti","year":"2013","unstructured":"Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol. 2013;14(4):297\u2013305. https:\/\/doi.org\/10.1016\/s1470-2045(13)70035-4","journal-title":"Lancet Oncol."},{"key":"8225_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30380-2","author":"V Galimberti","year":"2018","unstructured":"Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018. https:\/\/doi.org\/10.1016\/s1470-2045(18)30380-2","journal-title":"Lancet Oncol."},{"issue":"1","key":"8225_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1245\/s10434-012-2569-y","volume":"20","author":"M Sol\u00e1","year":"2013","unstructured":"Sol\u00e1 M, Alberro JA, Fraile M, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048\/13\/2000. Ann Surg Oncol. 2013;20(1):120\u2013127. https:\/\/doi.org\/10.1245\/s10434-012-2569-y","journal-title":"Ann Surg Oncol."},{"issue":"24","key":"8225_CR27","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(24):3657\u20133663. https:\/\/doi.org\/10.1200\/jco.2006.07.4062","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"32","key":"8225_CR28","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Chadha M, Moni J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) Trial. J Clin Oncol Off J Am Soc Clin Oncol. 2014;32(32):3600\u20133606. https:\/\/doi.org\/10.1200\/jco.2014.56.5838","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"7131","key":"8225_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/bmj.316.7131.606","volume":"316","author":"DJ Torgerson","year":"1998","unstructured":"Torgerson DJ, Roland M. What is Zelen\u2019s design? BMJ. 1998;316(7131):606. https:\/\/doi.org\/10.1136\/bmj.316.7131.606","journal-title":"BMJ."},{"issue":"1","key":"8225_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ije\/dyw050","volume":"46","author":"JM van der Velden","year":"2017","unstructured":"van der Velden JM, Verkooijen HM, Young-Afat DA, et al. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials? Int J Epidemiol. 2017;46(1):96\u2013102. https:\/\/doi.org\/10.1093\/ije\/dyw050","journal-title":"Int J Epidemiol."},{"key":"8225_CR31","doi-asserted-by":"crossref","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions. http:\/\/handbook-5-1.cochrane.org\/. Accessed 28 Jan 2019.","DOI":"10.1002\/9781119536604.ch1"},{"issue":"2","key":"8225_CR32","first-page":"149","volume":"30","author":"L Nardone","year":"2005","unstructured":"Nardone L, Palazzoni G, D\u2019Angelo E, et al. Impact of dose and volume on lymphedema. Rays. 2005;30(2):149\u2013155.","journal-title":"Rays."},{"issue":"3","key":"8225_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/028418600750013113","volume":"39","author":"SM Bentzen","year":"2000","unstructured":"Bentzen SM, Dische S. Morbidity related to axillary irradiation in the treatment of breast cancer. Acta Oncol Stockh Swed. 2000;39(3):337\u2013347.","journal-title":"Acta Oncol Stockh Swed."},{"issue":"4","key":"8225_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer. N Engl J Med. 2015;373(4):307\u2013316.","journal-title":"N Engl J Med."},{"issue":"4","key":"8225_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373(4):317\u2013327. https:\/\/doi.org\/10.1056\/nejmoa1415369","journal-title":"N Engl J Med."},{"issue":"5","key":"8225_CR36","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.ijrobp.2013.03.021","volume":"86","author":"C Hennequin","year":"2013","unstructured":"Hennequin C, Bossard N, Servagi-Vernat S, et al. Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys. 2013;86(5):860\u2013866. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.03.021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"8225_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13014-015-0568-4","volume":"10","author":"W Budach","year":"2015","unstructured":"Budach W, B\u00f6lke E, Kammers K, Gerber PA, Nestle-Kr\u00e4mling C, Matuschek C. Adjuvant radiation therapy of regional lymph nodes in breast cancer - a meta-analysis of randomized trials- an update. Radiat Oncol Lond Engl. 2015;10:258. https:\/\/doi.org\/10.1186\/s13014-015-0568-4","journal-title":"Radiat Oncol Lond Engl."},{"key":"8225_CR38","unstructured":"Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer - Full Text View - ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03488693. Accessed 26 Dec 2019."},{"issue":"1","key":"8225_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.yasu.2017.03.013","volume":"51","author":"LC Ozcan","year":"2017","unstructured":"Ozcan LC, Giuliano AE. Is axillary lymph node dissection necessary after a positive sentinel lymph node biopsy? Adv Surg. 2017;51(1):165\u2013178. https:\/\/doi.org\/10.1016\/j.yasu.2017.03.013","journal-title":"Adv Surg."},{"key":"8225_CR40","doi-asserted-by":"publisher","unstructured":"Glechner A, W\u00f6ckel A, Gartlehner G, et al. Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. Eur J Cancer Oxf Engl 1990. 2013;49(4):812\u2013825. https:\/\/doi.org\/10.1016\/j.ejca.2012.09.010","DOI":"10.1016\/j.ejca.2012.09.010"},{"key":"8225_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijsu.2016.08.022","volume":"34","author":"T-W Huang","year":"2016","unstructured":"Huang T-W, Kuo KN, Chen K-H, et al. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system. Int J Surg Lond Engl. 2016;34:73\u201380. https:\/\/doi.org\/10.1016\/j.ijsu.2016.08.022","journal-title":"Int J Surg Lond Engl."},{"key":"8225_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s40064-016-1712-9","volume":"5","author":"M Schmidt-Hansen","year":"2016","unstructured":"Schmidt-Hansen M, Bromham N, Hasler E, Reed MW. Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses. SpringerPlus. 2016;5:85. https:\/\/doi.org\/10.1186\/s40064-016-1712-9","journal-title":"SpringerPlus."},{"issue":"1","key":"8225_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cdtm.2017.01.005","volume":"3","author":"M Zhao","year":"2017","unstructured":"Zhao M, Liu W-G, Zhang L, et al. Can axillary radiotherapy replace axillary dissection for patients with positive sentinel nodes? A systematic review and meta-analysis. Chronic Dis Transl Med. 2017;3(1):41\u201350. https:\/\/doi.org\/10.1016\/j.cdtm.2017.01.005","journal-title":"Chronic Dis Transl Med."},{"issue":"1","key":"8225_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s12885-017-3361-y","volume":"17","author":"J de Boniface","year":"2017","unstructured":"de Boniface J, Frisell J, Andersson Y, et al. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial. BMC Cancer. 2017;17(1):379. https:\/\/doi.org\/10.1186\/s12885-017-3361-y","journal-title":"BMC Cancer."},{"issue":"12","key":"8225_CR45","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","volume":"27","author":"A Goyal","year":"2015","unstructured":"Goyal A, Dodwell D. POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. Clin Oncol R Coll Radiol G B. 2015;27(12):692\u2013695. https:\/\/doi.org\/10.1016\/j.clon.2015.07.005","journal-title":"Clin Oncol R Coll Radiol G B."},{"key":"8225_CR46","unstructured":"Protocol 14PRT\/0519. https:\/\/www.thelancet.com\/doi\/story\/10.1016\/html.2014.12.08.1563. Accessed January 28, 2019."},{"issue":"1","key":"8225_CR47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1186\/s12885-018-5053-7","volume":"18","author":"G Houvenaeghel","year":"2018","unstructured":"Houvenaeghel G, Cohen M, Raro P, et al. Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node. BMC Cancer. 2018;18(1):1153. https:\/\/doi.org\/10.1186\/s12885-018-5053-7","journal-title":"BMC Cancer."},{"issue":"4","key":"8225_CR48","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1684\/bdc.2014.1916","volume":"101","author":"G Houvenaeghel","year":"2014","unstructured":"Houvenaeghel G, Resbeut M, Boher J-M. [Sentinel node invasion: is it necessary to perform axillary lymph node dissection? Randomized trial SERC]. Bull Cancer (Paris). 2014;101(4):358\u2013363. https:\/\/doi.org\/10.1684\/bdc.2014.1916","journal-title":"Bull Cancer (Paris)."},{"key":"8225_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.breast.2016.06.016","volume":"30","author":"C Tinterri","year":"2016","unstructured":"Tinterri C, Canavese G, Bruzzi P, Dozin B. SINODAR ONE, an ongoing randomized clinical trial to assess the role of axillary surgery in breast cancer patients with one or two macrometastatic sentinel nodes. Breast Edinb Scotl. 2016;30:197\u2013200. https:\/\/doi.org\/10.1016\/j.breast.2016.06.016","journal-title":"Breast Edinb Scotl."},{"issue":"11","key":"8225_CR50","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1245\/s10434-018-6639-7","volume":"25","author":"SA Acuna","year":"2018","unstructured":"Acuna SA, Chesney TR, Amarasekera ST, Baxter NN. Defining non-inferiority margins for quality of surgical resection for rectal cancer: a Delphi consensus study. Ann Surg Oncol. 2018;25(11):3171\u20133178. https:\/\/doi.org\/10.1245\/s10434-018-6639-7","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"8225_CR51","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/SLA.0000000000003072","volume":"269","author":"SA Acuna","year":"2019","unstructured":"Acuna SA, Chesney TR, Ramjist JK, Shah PS, Kennedy ED, Baxter NN. Laparoscopic versus open resection for rectal cancer: a noninferiority meta-analysis of quality of surgical resection outcomes. Ann Surg. 2019;269(5):849\u2013855. https:\/\/doi.org\/10.1097\/sla.0000000000003072","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-020-08225-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08225-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:14:16Z","timestamp":1612311256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-020-08225-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["8225"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08225-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}